AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2026)
AVITA Medical's (RCEL) quarterly Income from Continuing Operations came in at 1409000.0 in Q4 2025, up 87.83% YoY from 750153.34 in Q4 2024, and up 89.32% on a QoQ basis from 13187000.0 in Q3 2025.
AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Income from Continuing Operations data on file, last reported at 1409000.0 in Q4 2025.
- Quarterly Income from Continuing Operations rose 87.83% year-over-year to 1409000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38375000.0 (up 37.94% YoY) and the FY2025 annual result came in at 38375000.0, up 37.94% from the prior year.
- Income from Continuing Operations improved to 1409000.0 in Q4 2025, from 13187000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 21411000.0 in Q4 2022 to a low of 18658000.0 in Q1 2024.
- A 5-year average of 9033500.0 and a median of 10152000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 133.0% — and 2025, when it surged 87.83%.
- Tracing RCEL's Income from Continuing Operations over 5 years: stood at 16663000.0 in 2021, then jumped by 228.49% to 21411000.0 in 2022, then slumped by 133.0% to 7065000.0 in 2023, then tumbled by 63.85% to 11576000.0 in 2024, then surged by 87.83% to 1409000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 1409000.0 (Q4 2025), 13187000.0 (Q3 2025), and 9920000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | AVITA Medical | 309.04 Mn | 297.90 Mn | 17.77 Mn | -7.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.66 Mn |
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | -13.19 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -13.86 Mn |
| Dec 31, 2024 | -11.58 Mn |
| Sep 30, 2024 | -16.21 Mn |
| Jun 30, 2024 | -15.39 Mn |
| Mar 31, 2024 | -18.66 Mn |
| Dec 31, 2023 | -7.07 Mn |
| Sep 30, 2023 | -8.71 Mn |
| Jun 30, 2023 | -10.38 Mn |
| Mar 31, 2023 | -9.22 Mn |
| Dec 31, 2022 | 21.41 Mn |
| Sep 30, 2022 | -5.59 Mn |
| Mar 31, 2022 | -9.46 Mn |
| Sep 30, 2021 | -16.66 Mn |
| Jun 30, 2021 | -10.72 Mn |
| Mar 31, 2021 | -6.00 Mn |
| Dec 31, 2020 | -5.64 Mn |